Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2013-07-30

Clinical Trial Update: Combination of Cisplatin Plus Gemcitabine Induction Chemotherapy and Intensity-modulated radiotherapyIntensity-modulated Radiotherapy With or Without Concurrent Cisplatin for NPC [Phase 2, Phase 3]

View source ↗

Summary

The study investigates induction chemotherapy with cisplatin and gemcitabine plus intensity-modulated radiotherapy, with or without concurrent cisplatin, for na…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CISPLATIN (cisplatin)
  • Gemcitabine (Gemcitabine)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Nasopharyngeal Carcinoma | Phase 2, Phase 3 | Status: UNKNOWN